Selective retina therapy with real-time feedback-controlled technology in central serous chorioretinopathy: a 24-month follow-up real-world prospective study.
Chang Ki YoonHyeong Gon YuPublished in: BMJ open ophthalmology (2024)
Our results suggest that SRT with RTF technology is a long-term safe treatment with anatomical improvement for patients with CSC.